SLS - SELLAS gains on FDA orphan drug status for its SLS009 October, 11 2023 09:05 AM SELLAS Life Sciences Group Inc. 2023-10-11 09:05:14 ET More on SELLAS Life Sciences SELLAS Phase 3 study for AML drug to continue without modifications Seeking Alpha’s Quant Rating on SELLAS Life Sciences For further details see: SELLAS gains on FDA orphan drug status for its SLS009